Terms: = Breast cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Treatment
8 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to myh9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. LAMC2 mitigates ER stress by enhancing ER-mitochondria interaction via binding to myh9 and MYH10.
Tong D; Zhou J; Zhou J; Wang X; Gao B; Rui X; Liu L; Chen Q; Huang C
Cancer Gene Ther; 2024 Jan; 31(1):43-57. PubMed ID: 37891404
[TBL] [Abstract] [Full Text] [Related]
3. HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
Alanazi SM; Feroz W; Mishra R; Kilroy MK; Patel H; Yuan L; Storr SJ; Garrett JT
PLoS One; 2023; 18(5):e0285251. PubMed ID: 37200287
[TBL] [Abstract] [Full Text] [Related]
4. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating myh9-Mediated GSK3β/β-Catenin Signaling.
Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
[TBL] [Abstract] [Full Text] [Related]
5. High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors.
Robinson TJ; Pai M; Liu JC; Vizeacoumar F; Sun T; Egan SE; Datti A; Huang J; Zacksenhaus E
Cell Cycle; 2013 Sep; 12(18):3013-24. PubMed ID: 23974104
[TBL] [Abstract] [Full Text] [Related]
6. Whole-genome analysis informs breast cancer response to aromatase inhibition.
Ellis MJ; Ding L; Shen D; Luo J; Suman VJ; Wallis JW; Van Tine BA; Hoog J; Goiffon RJ; Goldstein TC; Ng S; Lin L; Crowder R; Snider J; Ballman K; Weber J; Chen K; Koboldt DC; Kandoth C; Schierding WS; McMichael JF; Miller CA; Lu C; Harris CC; McLellan MD; Wendl MC; DeSchryver K; Allred DC; Esserman L; Unzeitig G; Margenthaler J; Babiera GV; Marcom PK; Guenther JM; Leitch M; Hunt K; Olson J; Tao Y; Maher CA; Fulton LL; Fulton RS; Harrison M; Oberkfell B; Du F; Demeter R; Vickery TL; Elhammali A; Piwnica-Worms H; McDonald S; Watson M; Dooling DJ; Ota D; Chang LW; Bose R; Ley TJ; Piwnica-Worms D; Stuart JM; Wilson RK; Mardis ER
Nature; 2012 Jun; 486(7403):353-60. PubMed ID: 22722193
[TBL] [Abstract] [Full Text] [Related]
7. The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells.
Derycke L; Stove C; Vercoutter-Edouart AS; De Wever O; Dollé L; Colpaert N; Depypere H; Michalski JC; Bracke M
Int J Dev Biol; 2011; 55(7-9):835-40. PubMed ID: 22161839
[TBL] [Abstract] [Full Text] [Related]
8. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
Leong S; McKay MJ; Christopherson RI; Baxter RC
J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
[TBL] [Abstract] [Full Text] [Related]
